Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × CTLA-4 Antigen × 1 year × Clear all

Sponsor

Conditions

Melanoma 13 Carcinoma, Renal Cell 10 Neoplasm Metastasis 6 Prostatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Myelodysplastic Syndromes 4 Lung Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Leukemia, Myeloid, Acute 3 Carcinoma, Transitional Cell 3 Brain Neoplasms 3 Uveal Melanoma 2 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2 Penile Neoplasms 2 Mycosis Fungoides 2 Meningioma 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Histiocytoma, Malignant Fibrous 2 Glioblastoma 2

Interventions

Rituximab 47 Cyclophosphamide 38 ibrutinib 22 fludarabine 22 acalabrutinib 20 venetoclax 18 Bendamustine Hydrochloride 18 zanubrutinib 15 Lenalidomide 15 CT-P10 13 fludarabine phosphate 12 Cytarabine 12 pirtobrutinib 11 obinutuzumab 11 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Etoposide 9 Vincristine 8 Doxorubicin 8 Biopsy 8 glofitamab 7 Whole-Body Irradiation 7 Mycophenolic Acid 6 Methotrexate 6 Melphalan 6 Peripheral Blood Stem Cell Transplantation 5 Immunotherapy, Adoptive 5 Cyclosporine 5 orelabrutinib 4 brexucabtagene autoleucel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡